Adipocytokines: Emerging therapeutic targets for pain management.

Shao-Jie Gao, Dai-Qiang Liu, Dan-Yang Li, Jia Sun, Long-Qing Zhang, Jia-Yi Wu, Fan-He Song, Ya-Qun Zhou, Wei Mei

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 May

filter terms:

Although pain has lower mortality rates than cancer, diabetes and stroke, pain is a predominate source of distress and disability. However, the management of pain remains an enormous problem. Many drugs used to pain treatment have more or less side effects. Therefore, the development of novel therapeutic target is critical for the treatment of pain. Notably, studies have shown that adipocytokines have a dual role in pain. Growing shreds of evidence shows that the levels of adipocytokines are upregulated or downregulated in the development of pain. In addition, substantial evidence indicates that regulation of adipocytokines levels in models of pain attenuates or promotes pain behaviors. In this review, we summarized and discussed the effect of adipocytokines in pain. These evidence indicates that adipocytokines attenuate or promote pain behaviors through interacting with their receptors, activating serotonin pathway, interacting with μ-opioid receptor, activating microglia, infiltrating macrophage and so on. Overall, adipocytokines have some potential in treating pain, but the underlying mechanisms remain unclear and need to be further studied. Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Citation

Shao-Jie Gao, Dai-Qiang Liu, Dan-Yang Li, Jia Sun, Long-Qing Zhang, Jia-Yi Wu, Fan-He Song, Ya-Qun Zhou, Wei Mei. Adipocytokines: Emerging therapeutic targets for pain management. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022 May;149:112813